On Monday, Las Vegas Sands Corp. (NYSE:LVS)’s shares declined -0.46% to $52.00.
Las Vegas Sands Corp. (LVS) have exchanged hands as contrast to its average daily volume of 5.40 million shares.
One factor driving casinos higher this afternoon is Credit Suisse’s belief that the Macau gaming hub in China is starting to show some improvements, Barron’s reports.
For the month of May Macau posted a 37% decline in gaming revenue. The gambling district is still struggling one year after the Chinese government’s anticorruption crackdown began, which resulted in VIP players avoiding the tables.
Las Vegas Sands Corp. develops, owns, and operates integrated resorts in Asia and the United States. The company owns and operates The Venetian Macao Resort Hotel, Sands Cotai Central, the Four Seasons Hotel Macao, the Plaza Casino, and the Sands Macao in Macau, the People’s Republic of China.
Amicus Therapeutics, Inc. (NASDAQ:FOLD)’s shares dropped -2.37% to $14.00.
Amicus Therapeutics, Inc. (FOLD) declared the pricing of an underwritten offering of 16,981,132 shares of its common stock at $13.25 per share. The gross proceeds from the offering to Amicus are predictable to be $225 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Amicus. In addition, Amicus has granted the underwriters a 30-day option to purchase up to an additional 2,547,170 shares of its common stock. The offering is predictable to close on June 17, 2015, subject to customary closing conditions.
J.P. Morgan Securities LLC and Goldman, Sachs & Co. are acting as joint book-running managers for the offering. Cowen and Company, LLC is acting as lead manager and Janney Montgomery Scott LLC is acting as co-manager for the offering.
Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its product candidate is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease. The company’s development programs include next-generation ERTs for lysosomal storage disorders (LSDs), such as Fabry disease, Pompe disease, and Mucopolysaccharidosis Type I.
At the end of Monday’s trade, Kroger Co (NYSE:KR)‘s shares surged 0.13% to $71.75.
Kroger Co (KR) will webcast the annual meeting of shareholders starting at 11 a.m. (ET) on Thursday, June 25, 2015.
The meeting will be broadcast online at ir.kroger.com. Click on “Events, Presentations & Webcasts” to access the event. An on-demand replay of the webcast will be accessible from about 1 p.m. (ET) Thursday, June 25 through Thursday, July 9, 2015.
Kroger, one of the world’s largest retailers, employs nearly 400,000 associates who serve customers in 2,625 supermarkets and multi-department stores in 34 states and the District of Columbia under two dozen local banner names counting Kroger, City Market, Dillons, Food 4 Less, Fred Meyer, Fry’s, Harris Teeter, Jay C, King Soopers, QFC, Ralphs and Smith’s. The company also operates 782 convenience stores, 326 fine jewelry stores, 1,330 supermarket fuel centers and 37 food processing plants in the U.S. Recognized by Forbes as the most generous company in America, Kroger supports hunger relief, breast cancer awareness, the military and their families, and more than 30,000 schools and community organizations. Kroger contributes food and funds equal to 200 million meals a year through more than 100 Feeding America food bank partners. A leader in supplier diversity, Kroger is a proud member of the Billion Dollar Roundtable and the U.S. Hispanic Chamber’s Million Dollar Club.
The Kroger Co., together with its auxiliaries, operates as a retailer in the United States and internationally. It also manufactures and processes food for sale in its supermarkets. The company operates retail food and drug stores, multi-department stores, jewelry stores, and convenience stores.
Mosaic Co (NYSE:MOS), ended its Monday’s trading session with -0.20% loss, and closed at $44.45.
Mosaic Co (MOS) formerly Hybrid Paytech World Inc. (HPT), a technology leader in the digital incentives, couponing and payment space, declared recently that on June 5 th, 2015, the Autorité des Marchés Financiers (the “AMF”) issued a partial revocation of the cease trade order issued on May 19th, 2015 solely to permit the closing of a financing. The cease trade order was issued because Mobi724 was unable to file its annual financial statements, MD&A and related CEO and CFO certificates for its fiscal year ended December 31, 2014 (the “Year End Filings”) by the filing deadline of April 30, 2015 as prescribed by National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102). The partial revocation of the cease trade order will allow Mobi724 to complete a private placement to issue a maximum of 36 363 637 common shares at a price of $ 0.0825 for the aggregate amount of $3,000,000. The subscribers shall also be issued one common share purchase warrant for every common share issued on the first $2,000,000 at an exercise price of $0.0825 exercisable between November 15, 2015 and March 31st 2016 after which they shall expire. The distribution will only take place in Quebec.
The funds raised shall permit Mobi724 to prepare and finalize Year End Filings, to prepare its interim financial statements, interim MD&A and related CEO and CFO certificates for the interim period ended March 31, 2015 (the “Interim Filings”), to file a full revocation order within 60 days from the closing of the private placement, to satisfy ongoing debt obligations, to pay past due payroll expenses and to satisfy minimum overhead expenses to sustain ongoing operations.
The Mosaic Company produces and markets concentrated phosphate and potash crop nutrients for the agricultural industry worldwide. It operates through two segments, Phosphates and Potash. The Phosphates segment owns and operates mines in Florida. It offers concentrated phosphate crop nutrients, such as diammonium phosphate, monoammonium phosphate, and ammoniated phosphate products. This segment also offers phosphate-based animal feed ingredients primarily under the Biofos and Nexfos brand names.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
